93 related articles for article (PubMed ID: 1389474)
1. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
[TBL] [Abstract][Full Text] [Related]
2. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
3. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
4. The relevance of oncogenes as prognostic markers in cervical cancer.
Soh LT; Heng D; Lee IW; Ho TH; Hui KM
Int J Gynecol Cancer; 2002; 12(5):465-74. PubMed ID: 12366664
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenes.
Rygaard K; Slebos RJ; Spang-Thomsen M
Int J Cancer; 1991 Sep; 49(2):279-84. PubMed ID: 1652570
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid-containing phosphatidylethanolamine enhances HL-60 cell differentiation by regulation of c-jun and c-myc expression.
Ishigamori H; Hosokawa M; Kohno H; Tanaka T; Miyashita K; Takahashi K
Mol Cell Biochem; 2005 Jul; 275(1-2):127-33. PubMed ID: 16335792
[TBL] [Abstract][Full Text] [Related]
7. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
8. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
[TBL] [Abstract][Full Text] [Related]
9. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
Yuen MF; Wu PC; Lai VC; Lau JY; Lai CL
Cancer; 2001 Jan; 91(1):106-12. PubMed ID: 11148566
[TBL] [Abstract][Full Text] [Related]
12. c-myc oncogene expression and clinical outcome in carcinoma of the cervix.
Sowani A; Ong G; Dische S; Quinn C; White J; Soutter P; Waxman J; Sikora K
Mol Cell Probes; 1989 Jun; 3(2):117-23. PubMed ID: 2671679
[TBL] [Abstract][Full Text] [Related]
13. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
14. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry.
Porter MJ; Field JK; Leung SF; Lo D; Lee JC; Spandidos DA; van Hasselt CA
Acta Otolaryngol; 1994 Jan; 114(1):105-9. PubMed ID: 8128845
[TBL] [Abstract][Full Text] [Related]
15. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
16. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
17. Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the Ha-ras-1 and/or c-myc genes.
Polischouk AG; Scotnikova OI; Sergeeva NS; Zharinov GM; Lewensohn R; Zhivotovsky B
Eur J Cancer; 1997 May; 33(6):942-9. PubMed ID: 9291819
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.
Bourhis J; Le MG; Barrois M; Gerbaulet A; Jeannel D; Duvillard P; Le Doussal V; Chassagne D; Riou G
J Clin Oncol; 1990 Nov; 8(11):1789-96. PubMed ID: 2230867
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix.
Symonds RP; Burnett RA; Habeshaw T; Kaye SB; Snee MP; Watson ER
Br J Cancer; 1989 Mar; 59(3):473-5. PubMed ID: 2467687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
